Coursera Bets $100 Million That Andrew Ng Can Do What Coursera Can’t

Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

YouTube

CAR T and Bispecific Antibody Therapies in Multiple Myeloma

Dana-Farber Cancer Institute via YouTube

Start learning Write review
TrainSec Ad

Learn EDR Internals: Research & Development From The Masters

Learn More → Coursera Ad

AI, Data Science & Cloud Certificates from Google, IBM & Meta

Learn More →

Overview

Google, IBM & Meta Certificates – 40% Off
One plan covers every Professional Certificate on Coursera.
Unlock All Certificates
In this 42-minute educational video, Dr. Shonali Midha from Dana-Farber Cancer Institute explores the applications of CAR T-cell therapy and bispecific antibody therapy for patients with relapsed/refractory multiple myeloma. Discover the latest developments in immune-based treatment approaches for multiple myeloma, including clinical outcomes, patient selection criteria, and emerging therapeutic strategies. Gain valuable insights into how these innovative immunotherapies are transforming the treatment landscape for patients with this challenging hematologic malignancy.

Syllabus

CAR T and Bispecific Antibody Therapies in Multiple Myeloma

Taught by

Dana-Farber Cancer Institute

Reviews

Start your review of CAR T and Bispecific Antibody Therapies in Multiple Myeloma

Start learning

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Sign up for free
Someone learning on their laptop while sitting on the floor.